A GLP-1 receptor agonist (Ozempic/Wegovy) extensively researched for type 2 diabetes and obesity/weight management.
Mimics the gut hormone GLP-1, binding GLP-1 receptors in pancreas, brain and GI tract. Enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic appetite centres to increase satiety and reduce food intake.
Bars reflect the strength & volume of research evidence for each use — not a guarantee of results.
No reviews yet. If you've used Semaglutide, be the first to share what it helped with and any side effects.
⚠️ Educational research information only — not medical advice. Many peptides are sold strictly for laboratory research and are not approved treatments. The evidence scores reflect research interest and strength, not efficacy or safety for any individual. Always consult a qualified professional.